Patents Assigned to Arakis Ltd.
  • Treatment of inflammatory disorders
    Patent number: 7034028
    Abstract: A method of treating an inflammatory disease or an autoimmune disease in a subject, comprises the administration of mefloquine.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: April 25, 2006
    Assignee: Arakis Ltd.
    Inventors: Benjamin Mark Skead, Robin Mark Bannister, Alan Rothaul
  • Corticosteroid formulation
    Patent number: 6488960
    Abstract: The present invention pertains to a unit dose formulation comprising 0.25 to 2 mg of a corticosteroid. This small dose can be used to treat rheumatoid arthritis, especially if adapted to release at least 90% by weight of the corticosteroid, 2 to 8 hours after administration.
    Type: Grant
    Filed: September 13, 2001
    Date of Patent: December 3, 2002
    Assignee: Arakis Ltd.
    Inventor: Hazel Judith Bardsley